Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

  1. Cuneo, A.
  2. Mato, A.R.
  3. Rigolin, G.M.
  4. Piciocchi, A.
  5. Gentile, M.
  6. Laurenti, L.
  7. Allan, J.N.
  8. Pagel, J.M.
  9. Brander, D.M.
  10. Hill, B.T.
  11. Winter, A.
  12. Lamanna, N.
  13. Tam, C.S.
  14. Jacobs, R.
  15. Lansigan, F.
  16. Barr, P.M.
  17. Shadman, M.
  18. Skarbnik, A.P.
  19. Pu, J.J.
  20. Sehgal, A.R.
  21. Schuster, S.J.
  22. Shah, N.N.
  23. Ujjani, C.S.
  24. Roeker, L.
  25. Orlandi, E.M.
  26. Billio, A.
  27. Trentin, L.
  28. Spacek, M.
  29. Marchetti, M.
  30. Tedeschi, A.
  31. Ilariucci, F.
  32. Gaidano, G.
  33. Doubek, M.
  34. Farina, L.
  35. Molica, S.
  36. Di Raimondo, F.
  37. Coscia, M.
  38. Mauro, F.R.
  39. de la Serna, J.
  40. Medina Perez, A.
  41. Ferrarini, I.
  42. Cimino, G.
  43. Cavallari, M.
  44. Cucci, R.
  45. Vignetti, M.
  46. Foà, R.
  47. Ghia, P.
  48. Show all authors +
Journal:
Cancer Medicine

ISSN: 2045-7634

Year of publication: 2020

Volume: 9

Issue: 22

Pages: 8468-8479

Type: Article

DOI: 10.1002/CAM4.3470 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus